A globally accessible investment fund dedicated to subsidizing nanoparticle-based cancer treatments for underserved populations. Funded by a percentage of profits from pharmaceutical companies developing these treatments and philanthropic donations, ensures equitable access regardless of socioeconomic status by covering treatment costs, travel expenses, and aftercare. It promotes inclusivity and reduces healthcare disparities.